Ovitrelle 250mcg by Merck is a pharmaceutical-grade recombinant hCG (choriogonadotropin alfa), documented in reproductive endocrinology research for its role in mimicking luteinizing hormone (LH) activity. Unlike traditional urinary-derived hCG, Ovitrelle is a pure, lab-synthesized r-hCG, offering documented consistency in potency and purity.
 
✔ Key Research Insights
- Studied for its LH-receptor agonist activity at Leydig cells in male research subjects
- Documented for its role in stimulating the hypothalamic-pituitary-testicular axis (HPTA) in endocrinological research
- Investigated in reproductive research for its role in ovulation induction
- High purity recombinant synthesis, distinct from urinary-derived hCG formulations
 
📦 Product Specifications
- Manufacturer: Merck
- Form: Prefilled single-use injection (subcutaneous)
- Molecule: Recombinant hCG (Choriogonadotropin Alfa)
- Concentration: 250 mcg (~6,500 IU biological activity)
- Volume: 0.5 ml per syringe